PROLOG: Reproductive Endocrinology & Infertility

页数:0

价格:81.00

isbn号码:9780915473526

具体描述

1 Risk of venous thrombosis with oral contraceptives Two months after beginning low-dose combination oral contraceptives (OCs)， a previously healthy 18-year-old college student presents to the emergency room with "the worst headache of my life." Her condition is diagnosed as cerebral sinus thrombosis. Further evaluation is most likely to reveal * (A) resistance to activated protein C (B) protein S deficiency (d~) antithrombin HI deficiency (D) factor VIII deficiency (E) idiopathic thrombocytopenic purpura Oral contraceptives have been shown to have small pregnancy. Resistance to activated protein C is consid- effects on both procoagulant and anticoagulant factors， ered to be present if there is less than a twofold prolonga- There is no evidence， however， that any OC-related tion in the activated partial thromboplastin time when change in any clotting factor has significant clinical activated protein C is added to the plasma of the patient effects. Nevertheless， it is clear that certain inherited dis- being tested. The possibility of a lupus anticoagulant or orders put a woman taking OCs at increased risk of an occult malignancy also should be considered iu venous thrombosis， women who experience a thrombotic episode while tak- Protein C and protein S are two major vitamin ing OCs. Moreover， combination OC use generally is K-dependent inhibitors of coagulation. Antithrombin III contraindicated in women with a history of idiopathic is a natural anticoagulant and an irreversible inhibitor of venous thromboembolism. thrombin and factors IXa， Xa， and Xla. Deficiencies of Still another mutation has been identified in the 3 protein C， protein S， and antithrombin III are inherited as untranslated region of the prothrombin gene (the substi- autosomal dominant disorders， accounting for 5-10% of tution of A for G at position 20210， sometimes termed all cases of unexplained venous thromboembolism， the G20210A prothrombin mutation)， which is present in If there is resistance to activated protein C， then coag- 2% of the general population and increases the risk of ulation is increased. Inherited resistance to activated pro- deep vein thrombosis by approximately threefold. tein C has been identified as the basis for 20-40% of Accumulating evidence indicates that carriers of the pro- cases of deep vein thrombosis. In almost all cases， resist- thrombin G20210A allele who also have other inherited anee to activated protein C is due to a geoe alteration of a thrombophilic conditions (deficiency of antithrombin single amino acid termed the factor V Leiden mutation. III， protein C， protein S， or the factor V Leiden mutation) The mutation， which appears to be present in about 5% of are more prone to recurrent thrombotic episodes. It has the normal population， is by far the most common cause been suggested that such individuals should be identified for recurrent venous thromboembolism. It is also the most as candidates for lifelong anticoagulation. Common abnormal finding among OC users who experi- If a patient has a family history of idiopathic venous enee venous thromboembolism. Several studies have thromboembolism or develops a thrombotic episode established that the factor V Leiden mutation greatly while using OCs， an evaluation to search for an underly- increases the risk of thrombosis for OC users. The risk of ing abnormality is warranted. The complexity of these cerebral venous thrombosis appears to be increased as inherited abnormalities may make evaluation difficult for much as 13-fold among OC users with the factor V the gynecologist， and referral to a hematologist may be Leiden mutation， the simplest approach. Direct measurement of aatithrom- Because venous thromboembolism in OC users is so bin lII， protein C， protein S， fibrinogen， and plasminogen rare， routine screening among potential OC users for deft- is indicated， as is determination of the prothrombin and elencms in the coagulation system does not seem justi- activated partial thromboplastin times. Activated protein fled. Furthermore， these inherited defects are uncommon， C resistance can be determined by performing a modified， and not all women with these abnormalities have clinical activated， partial thromboplastin time test， which meas- problems involving clotting. Such recommendations may ares the anticoagulant response to the addition of a stan- change， however， if the cost of screening decreases sub- dard amount of activated protein C. The presence of the stantially. Screening is warranted for women with a fam- factor V Leiden mutation can be determined by DNA ily history of idiopathic thrombosis and for those who analysis using the polymerase chain reaction to detect the develop a thrombotic episode while taking OCs or during presence of the base pair substitution. ]ndica/cs correct answer，

用户评价

这本书的装帧设计着实让人眼前一亮，硬壳封面搭配着典雅的深蓝色调，中央烫金的字体在灯光下低调地闪烁着专业感，这可不是那种随随便便就能在书店角落里找到的普通教材。初次翻开时，那种纸张的质地就传递出一种厚重和严谨，每一页的边缘都处理得非常精细，看得出出版社在制作上是下了真功夫的。内页的排版布局也极为考究，大段文字之间留白的拿捏恰到好处，使得即便是面对大量复杂的专业术语和图表时，眼睛也不会感到过度疲劳。特别是那些流程图和组织结构图，线条清晰，逻辑层次感极强，即便是初次接触这个领域的人，也能从视觉上快速把握住核心的知识脉络。我想，光是把它放在书架上，它本身就是一件颇具品味的藏书，那种散发出来的学术气息，绝对能提升整个书房的格调。这种对细节的执着，让我对书中内容的质量也自然而然地抱有了更高的期待，它给人的第一印象就是：这是一部值得珍视的参考资料，而非转瞬即逝的快餐读物。

老实说，这本书的定价对于普通学生来说可能略显昂贵，但从整体价值回报率来衡量，我认为它是一笔绝对值得的投资。它的信息密度极高，几乎没有一页是废话，读起来需要全神贯注，甚至可能需要反复回溯。但正是这种近乎苛刻的密度，保证了你每付出一点努力，都能获得相应的、高质量的知识回报。我对比了市面上几本同类的参考书，它们要么过于侧重某个细分领域而缺乏宏观视野，要么就是内容陈旧。而这本，它提供了一个无与伦比的、全面且深入的知识架构。如果你真的打算在这个专业领域深耕下去，把它作为你职业生涯中查阅和学习的“基石”之选，那么它的长期价值将远远超出你支付的标价。这本书代表了一种对专业知识的敬畏和对读者学习态度的尊重。

我必须指出，这本书的编纂团队显然汇集了该领域的顶尖智慧，其跨学科的视野令人印象深刻。阅读过程中，我惊喜地发现，它不仅仅局限于传统的内分泌学范畴，而是巧妙地整合了遗传学、免疫学，甚至是部分流行病学的最新研究成果。在讨论特定疾病的遗传易感性时，作者引用了最新的基因测序技术数据，并清晰地描绘了未来个性化治疗的可能性。这种将基础科学的最新突破快速桥接到临床应用层面的速度，表明这部作品的更新迭代速度非常快，它绝不是一本滞后于时代的研究汇编。这种与时俱进的生命力，对于我们这些需要紧跟科研前沿的专业人士来说，是至关重要的，它确保了我们所学到的知识依然处于学科的最前沿，具有真正的指导意义。

这本书的实用性绝对是教科书级别的，它超越了单纯的理论介绍，真正触及了临床实践中的痛点和前沿动态。我尤其欣赏它在处理病例分析时的那种细腻和周到。书中没有提供标准化的“标准答案”，而是设置了多种模拟情境，要求读者根据已有的检查结果和病史资料，自主推导出最可能的诊断路径和干预策略。这种互动式的学习方法，极大地锻炼了我的临床思维的严谨性。比如，对于一些罕见或疑难的激素紊乱案例，书中不仅详细分析了病理生理过程，还特别强调了在不同文化背景或资源受限环境下，如何调整诊疗方案的侧重点，这种全球化视野的融入，无疑让这本书的价值倍增。这不只是一本知识手册，更像是一位经验丰富的大师在手把手地指导你如何应对真实的临床挑战。

我花了整整一个周末的时间来研读其中关于基础生化反应机制的部分，说实话，那些晦涩难懂的分子生物学概念，通常是许多学术著作的“拦路虎”，但这本书的处理方式简直是化繁为简的大师级示范。作者似乎深谙“授人以渔”的道理，他们不是简单地堆砌公式和数据，而是构建了一个极其清晰的、由浅入深的逻辑链条。例如，在解释某个内分泌轴的反馈调节机制时，书中没有采用生硬的定义灌输，而是通过一个生动的、类比于复杂工业生产线的模型来阐述，这种叙事手法极大地降低了理解门槛。我发现自己以前在其他地方碰壁的几个关键知识点，在这本书里竟然能瞬间被打通，那种“豁然开朗”的感觉，是阅读一本优秀专业书籍最令人满足的体验。而且，书中引用的参考文献标注得非常规范和全面，每一句话的背后似乎都有坚实的科学证据支撑，这让我的阅读过程充满了信赖感。